{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:55Z","timestamp":1787004835444,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32CA200561-10"],"award-info":[{"award-number":["5T32CA200561-10"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","semthorcardiovascsurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1053\/j.semtcvs.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T19:49:14Z","timestamp":1747684154000},"page":"71-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Surgery for Local Consolidative Therapy in the Management of Oligometastatic Disease"],"prefix":"10.1053","volume":"38","author":[{"given":"Rajika","family":"Jindani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara B.","family":"Antonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib1","first-page":"8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin\u00a0Oncol"},{"issue":"12","key":"10.1053\/j.semtcvs.2025.05.003_bib2","first-page":"2109","article-title":"Definition of synchronous oligometastatic non-small cell lung cancer-a consensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J\u00a0Thorac\u00a0Oncol"},{"issue":"19","key":"10.1053\/j.semtcvs.2025.05.003_bib3","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.3390\/cancers13194822","article-title":"Classifying oligometastatic non-small cell lung cancer","volume":"13","author":"Blumenthaler","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"172","key":"10.1053\/j.semtcvs.2025.05.003_bib4","article-title":"Complex situations in lung cancer: multifocal disease, oligoprogression and oligorecurrence","volume":"33","author":"Werner","year":"2024","journal-title":"Eur\u00a0Respir\u00a0Rev"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"18","key":"10.1053\/j.semtcvs.2025.05.003_bib6","first-page":"1558","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J\u00a0Clin\u00a0Oncol"},{"issue":"5","key":"10.1053\/j.semtcvs.2025.05.003_bib7","first-page":"446","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J\u00a0Clin\u00a0Oncol"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib8","first-page":"109","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J\u00a0Natl\u00a0Cancer Inst"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib9","first-page":"S3","article-title":"Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial","volume":"102","author":"Palma","year":"2018","journal-title":"Int J\u00a0Radiat\u00a0Oncol\u00a0Biol\u00a0Phys"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.003_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PPO.0000000000000433","article-title":"Local ablative therapies for oligometastatic and oligoprogressive non-small cell lung cancer","volume":"26","author":"Jairam","year":"2020","journal-title":"Cancer J"},{"issue":"4","key":"10.1053\/j.semtcvs.2025.05.003_bib11","first-page":"635","article-title":"Local consolidative therapy versus systemic therapy alone for metastatic non-small cell lung cancer: a systematic review and meta-analysis","volume":"114","author":"Wu","year":"2022","journal-title":"Int J\u00a0Radiat\u00a0Oncol\u00a0Biol\u00a0Phys"},{"issue":"12","key":"10.1053\/j.semtcvs.2025.05.003_bib12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib13","first-page":"37","article-title":"Improved overall survival with comprehensive local consolidative therapy in synchronous oligometastatic non-small-cell lung cancer","volume":"21","author":"Mitchell","year":"2020","journal-title":"Clin\u00a0Lung Cancer"},{"issue":"6","key":"10.1053\/j.semtcvs.2025.05.003_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J\u00a0Natl\u00a0Cancer Inst"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.003_bib15","first-page":"364","article-title":"Lung resection after initial nonoperative treatment for non-small cell lung cancer","volume":"168","author":"Dunne","year":"2024","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/s13019-024-03191-y","article-title":"Long-term outcomes of surgical treatment of non-small cell lung cancer with oligometastatic disease involving only the brain in the era of PET\/CT","volume":"19","author":"Watari","year":"2024","journal-title":"J\u00a0Cardiothorac\u00a0Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2025.05.003_bib17","first-page":"1122","article-title":"Resection of the primary tumor and survival in patients with single-site synchronous oligometastatic non-small cell lung cancer: propensity-matched analysis of the national cancer database","volume":"238","author":"Rodriguez-Quintero","year":"2024","journal-title":"J\u00a0Am\u00a0Coll\u00a0Surg"},{"issue":"4","key":"10.1053\/j.semtcvs.2025.05.003_bib18","first-page":"1497","article-title":"MD Anderson Cancer Center Oligometastatic Lung Cancer Working Group. Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer","volume":"161","author":"Mitchell","year":"2021","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"5","key":"10.1053\/j.semtcvs.2025.05.003_bib19","first-page":"393","article-title":"Treatment of oligometastatic non-small cell lung cancer: an ASTRO\/ESTRO clinical practice guideline","volume":"13","author":"Iyengar","year":"2023","journal-title":"Pr\u00a0Radiat\u00a0Oncol"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.003_bib20","first-page":"495","article-title":"The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on surgical management of oligometastatic non-small cell lung cancer","volume":"119","author":"Antonoff","year":"2025","journal-title":"Ann\u00a0Thorac\u00a0Surg"},{"issue":"11","key":"10.1053\/j.semtcvs.2025.05.003_bib21","first-page":"1423","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat\u00a0Med"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.semcancer.2019.08.026","article-title":"Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers","volume":"60","author":"Zhao","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.003_bib23","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastas\u00a0Rev"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib24","first-page":"9","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat\u00a0Rev\u00a0Cancer"},{"issue":"11","key":"10.1053\/j.semtcvs.2025.05.003_bib25","first-page":"1423","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat\u00a0Med"},{"issue":"7","key":"10.1053\/j.semtcvs.2025.05.003_bib26","first-page":"3351","article-title":"Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer","volume":"10","author":"Rashdan","year":"2021","journal-title":"Transl\u00a0Lung Cancer Res"},{"issue":"7","key":"10.1053\/j.semtcvs.2025.05.003_bib27","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib28","article-title":"Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity","volume":"8","author":"Chen","year":"2020","journal-title":"J\u00a0Immunother\u00a0Cancer"},{"issue":"5","key":"10.1053\/j.semtcvs.2025.05.003_bib29","first-page":"1665","article-title":"A model to predict the use of surgical resection for advanced-stage non-small cell lung cancer patients","volume":"104","author":"David","year":"2017","journal-title":"Ann\u00a0Thorac\u00a0Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2025.05.003_bib30","first-page":"1929","article-title":"Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: evidence for surgery in advanced disease","volume":"167","author":"Deboever","year":"2024","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2025.05.003_bib31","first-page":"1166","article-title":"Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis","volume":"57","author":"Opitz","year":"2020","journal-title":"Eur\u00a0J\u00a0Cardiothorac\u00a0Surg"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.003_bib32","article-title":"Surgical complexity of pulmonary resections performed for oligometastatic NSCLC","volume":"3","author":"Antonoff","year":"2022","journal-title":"JTO Clin\u00a0Res Rep"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.xjon.2022.09.012","article-title":"Intraoperative challenges after induction therapy for non-small cell lung cancer: effect of nodal disease on technical complexity","volume":"12","author":"Feldman","year":"2022","journal-title":"JTCVS Open"},{"issue":"24","key":"10.1053\/j.semtcvs.2025.05.003_bib34","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.3390\/cancers13246374","article-title":"Patient selection for local aggressive treatment in oligometastatic non-small cell lung cancer","volume":"13","author":"Werner","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib35","first-page":"9993","article-title":"An umbrella review of socioeconomic status and cancer","volume":"15","author":"Li","year":"2024","journal-title":"Nat\u00a0Commun"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.003_bib36","article-title":"High barriers to treatment are associated with stereotactic radiation instead of surgery for patients with operable stage I non-small cell lung cancer\u2020","volume":"67","author":"Rodriguez-Quintero","year":"2024","journal-title":"Eur\u00a0J\u00a0Cardiothorac\u00a0Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2025.05.003_bib37","first-page":"5381","article-title":"Impact of travel burden on clinical outcomes in lung cancer","volume":"30","author":"Stoyanov","year":"2022","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1053\/j.semtcvs.2025.05.003_bib38","first-page":"1617","article-title":"Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer","volume":"167","author":"Eisenberg","year":"2024","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"8","key":"10.1053\/j.semtcvs.2025.05.003_bib39","first-page":"4688","article-title":"Osimertinib, surgery, and radiation therapy in treating patients with stage IIIB or IV non-small cell lung cancer with EGFR mutations (NORTHSTAR)","volume":"29","author":"Khan","year":"2022","journal-title":"Ann\u00a0Surg\u00a0Oncol"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib40","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.9624","article-title":"BRIGHTSTAR: a pilot trial of local consolidative therapy (LCT) with brigatinib in tyrosine kinase inhibitor (TKI)-na\u00efve ALK-rearranged advanced NSCLC","volume":"38","author":"Elamin","year":"2020","journal-title":"JCO"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib41","unstructured":"MDAnderson Cancer Center. Randomized phase III trial of local consolidation therapy (LCT) after nivolumab and ipilimumab for immunotherapy-naive patients with metastatic non\u2013small cell lung cancer (LONESTAR). PI: John Haymach, Open Label. Est Completion Date 12\/31\/2022. NCT03391869. \u3008https:\/\/clinicaltrials.gov\/search?term=NCT03391869\u3009. Accessed December 25, 2024."},{"key":"10.1053\/j.semtcvs.2025.05.003_bib42","unstructured":"\u201cClinical Trials.\u201d MD Anderson Cancer Center, www.mdanderson.org\/research\/departments-labs-institutes\/departments-divisions\/thoracic-cardiovascular-surgery\/clinical-trials.html. Accessed January 1,\u00a02025."},{"issue":"12","key":"10.1053\/j.semtcvs.2025.05.003_bib43","article-title":"Prognostic and predictive biomarkers of oligometastatic NSCLC: new insights and clinical applications","volume":"5","author":"Jongbloed","year":"2024","journal-title":"JTO Clin\u00a0Res Rep"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib44","article-title":"Benchmarking outcomes for molecularly characterized synchronous oligometastatic non-small-cell lung cancer reveals EGFR mutations to be associated with longer overall survival","volume":"7","author":"De","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.003_bib45","first-page":"847","article-title":"Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival\u2020","volume":"49","author":"Hishida","year":"2016","journal-title":"Eur\u00a0J\u00a0Cardiothorac\u00a0Surg"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.003_bib46","first-page":"444","article-title":"Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience","volume":"144","author":"Congedo","year":"2012","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib47","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3390\/cancers13081893","article-title":"Management of synchronous extrathoracic oligometastatic non-small cell lung cancer","volume":"13","author":"Jones","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semtcvs.2025.05.003_bib48","first-page":"732","article-title":"Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with firstline pembrolizumab: a retrospective observational study","volume":"13","author":"Chen","year":"2022","journal-title":"Thorac\u00a0Cancer"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067925000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067925000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:38:59Z","timestamp":1778794739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067925000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1043067925000607"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2025.05.003","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Surgery for Local Consolidative Therapy in the Management of Oligometastatic Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}